North America Startup Funding Rounds
Startups raising capital across North America. Compare the businesses, funding stages and investors active in the region.
- Rounds
- 2,300 Jan 1 – Oct 25, 2026
- Disclosed funding
- $210.9B 1908 disclosed amounts
- Median round
- $23M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| AP Develops, constructs, owns, and operates renewable energy assets | $200M | StrategicUndisclosed | Climate tech | United States | Investors | |
| V Provides intelligent software platforms for oncology care | $43M | Undisclosed | Healthtech | United States | Investors | |
| ZI Zepo IntelligenceCompany profile Zepo Intelligence develops workspace security software combining human-risk management and threat monitoring. Zepo Intelligence develops workspace security software combining human-risk management and threat monitoring. | $15M | Seed | Cybersecurity | United States | Investors | |
| MT Mirador TherapeuticsCompany profile Develops next-generation therapies for immune-mediated inflammatory and fibrotic diseases Develops next-generation therapies for immune-mediated inflammatory and fibrotic diseases | $250M | Series B | Biotech | United States | Investors | |
| A AI4EyesCompany profile AI4Eyes develops AI-assisted imaging and software to help eye-care professionals assess ocular conditions and plan care. AI4Eyes develops AI-assisted imaging and software to help eye-care professionals assess ocular conditions and plan care. | CA$3.7M | Undisclosed | AI | Canada | Investors Undisclosed | |
| AA Allos AICompany profile Causal AI and pharmaceutical development services for reformulating complex drugs and directing laboratory studies. Causal AI and pharmaceutical development services for reformulating complex drugs and directing laboratory studies. | $5M | Seed | AI | United States | Investors | |
| TB Trailhead BiosystemsCompany profile Develops human cells with defined molecular and functional properties for drug discovery and regenerative medicine Develops human cells with defined molecular and functional properties for drug discovery and regenerative medicine | $20M | Growth | Biotech | United States | Investors | |
| CA Cast AICompany profile Provides automation platform for operating cloud-native and AI workloads at scale Provides automation platform for operating cloud-native and AI workloads at scale | Undisclosed | StrategicUndisclosed | Developer tools | United States | Investors | |
| A AccelsiusCompany profile Two-phase liquid cooling for data centres running dense AI and high-performance computing workloads. Two-phase liquid cooling for data centres running dense AI and high-performance computing workloads. | $65M | Series B | Hardware | United States | Investors | |
| JT Develops regenerative biologics to restore tissue function | $33.5M | Series B | Biotech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
Tractian, Blacksmith, Greptile
132rounds3led - 2Andreessen Horowitz (a16z)
ASI, Eka Robotics, Town
98rounds19led - 3General Catalyst
Tractian, Different, Baba
70rounds7led - 4Alumni Ventures
Maxinsights, Daytona, Chariot Claims
60rounds0led - 5Khosla Ventures
Arda Industries, Tolan
59rounds6led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.